J&J, BMS arthritis drugs lowered death risk among COVID patients in federal study
J&J, BMS arthritis drugs lowered death risk among COVID patients [...]
J&J, BMS arthritis drugs lowered death risk among COVID patients [...]
Pfizer’s new vaccine R&D leader Anderson has a high bar [...]
Moderna, EU officials delay COVID-19 vaccine deliveries as demand falls [...]
Gilead names new manufacturing head in wake of recent hiccups [...]
Regeneron pays Sanofi $900M for full rights to cancer drug [...]
Bristol severs Russian ties as Novartis resurrects Ukraine business following [...]
FDA puts Sanofi’s Cialis prescription-to-OTC trial on hold, citing problems [...]
After flagging death risks, FDA rescinds accelerated approval for TG [...]
Regeneron’s cholesterol drug war heats up with lawsuit over Amgen’s [...]
Former AstraZeneca exec charged with insider trading in Daiichi Sankyo’s [...]